Xcout Intel
Aer Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Aer Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Aer Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Aer Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Aer Therapeutics, Inc.
Aer Therapeutics, Inc. is a biotechnology research company based in North Carolina focused on targeting mucus to improve lung health.
Aer Therapeutics, Inc. at a glance
Aer Therapeutics, Inc. is a biotechnology company headquartered in United States. It has raised at least $23.9M across the 3 funding rounds on record. Its most recent funding round raised $3M in August 2026. Xcout tracks 15 named people at Aer Therapeutics, Inc., including Thomas P. Mathers (Executive Chairman and Interim CEO).
Aer Therapeutics, Inc. leadership
- Thomas P. MathersExecutive Chairman and Interim CEO
- Thomas MathersChairman of the Board of Directors
- John FahyFounder and Chief Clinical Consultant
- William Thelin, PhDSVP, Drug Development
- Irina Gitlin, PhDVice President, Research and Development
- Blair CapelSenior Director, Finance and Administration
9 more named people on record for Aer Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Aer Therapeutics, Inc. funding rounds
At least $23.9M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $3M | — | |
| SEC Form D filing | $5M | — | |
| SEC Form D filing | $15.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Aer Therapeutics, Inc. news
- FundingPrivate placement (Form D)
Top 12 Aer Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Aer Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
AeroRx Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic obstructive pulmonary disease (COPD).
Similar biotechnology company
Sunterra Bio is a biopharmaceutical company focused on developing inhaled small-molecule therapies for rare pulmonary diseases. Headquartered in Carlsbad, California, the company advances targeted treatments for respiratory conditions.
Similar biotechnology company
Aiolos Bio is a biotechnology research company headquartered in San Francisco, California, focused on developing novel treatments for respiratory and asthma conditions. The clinical-stage biopharmaceutical firm was acquired by GSK to strengthen its drug development pipeline.
Similar biotechnology company
RaeSedo Holding, Inc. is a biotechnology company developing a novel class of therapeutics for asthma. The company is creating surfactant protein-A (SP-A) derived peptide therapies designed to reduce inflammation, mucus, and airway constriction for asthma patients.
Similar biotechnology company
Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company with principal executive offices located in Cambridge, Massachusetts. The company went public through a reverse merger and is involved in therapeutic acquisitions and development.
Biotech
Celea Therapeutics is a biopharmaceutical company focused on advancing transformative treatments for serious respiratory diseases.
Life Sciences
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to developing advanced therapeutics that address unmet medical needs. The company is headquartered in Raleigh and Research Triangle Park, North Carolina.
Similar biotechnology company
Expedition Therapeutics is a clinical-stage biotechnology company headquartered in San Francisco, California, developing novel oral small molecule therapies for serious inflammatory and respiratory diseases.
Similar biotechnology company
Avere Therapeutics is a biotechnology company headquartered in Philadelphia, Pennsylvania, focused on developing oral therapies for the treatment of IL-23-driven inflammatory diseases.
Similar biotechnology company
BreStem Therapeutics, Inc. is a clinical-stage biotechnology company located in Raleigh, North Carolina, focused on developing novel therapeutics to fight various diseases.
Biotech
Sionna Therapeutics is a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, focused on developing treatments for cystic fibrosis.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Aer Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Aer Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →